Sub-standard or Sub-legal? Distribution, Pharma Dossiers, and Fake-talk in India
In this article, I look at Indian pharma ‘dossiers’—the bundles of paperwork that testify to pharmaceutical quality and adherence to regulatory standards—and how they illustrate a wider and ongoing shift from a paradigm of drug safety to one of drug se…